Latest News and Press Releases
Want to stay updated on the latest news?
-
TRANSGENE (Paris : TNG) annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers le rapport semestriel au 30 juin 2024. Il peut être consulté sur le site...
-
TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2024. The...
-
Résultats financiers du 1er semestre 2024 et point sur l’activité Produit phare TG4050 (vaccin thérapeutique individualisé) : - Premiers signes de bénéfice clinique dans le cancer...
-
2024 Half-Year Results and Business Update Lead program TG4050 (individualized immunotherapy): – First signs of clinical benefit in adjuvant head and neck cancer reported at AACR 2024,...
-
Rapport Semestriel 2024 Pièce jointe TRANSGENE_RAPPORT-FINANCIER-SEMESTRIEL-2024_FR ...
-
2024 Half Year Financial Report Attachment TRANSGENE_HALF-YEAR-FINANCIAL-REPORT-2024_EN ...
-
BRISBANE, Australia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Orocobre Limited (ASX: ORE, TSX: ORL) (Orocobre or the Company), a dynamic global lithium chemicals producer, provides its financial results...
-
BRISBANE, Australia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Orocobre Limited (ASX: ORE, TSX: ORL) (Orocobre or the Company), a dynamic global lithium chemicals producer, provides its financial results...
-
BRISBANE, Australia, Feb. 16, 2020 (GLOBE NEWSWIRE) -- Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”) will release the 2020 Half-Year Financial Results on Friday 21 February...
-
BRISBANE, Australia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”), a dynamic global lithium chemicals supplier, today released its financial...